This is an observational, retrospective, UK & Ireland audit measuring patient adherence to
Rebif® injections with the RebiSmart™ injection device. Data will be collected from Multiple
Sclerosis (MS) patients who have been prescribed Rebif® and have been using the RebiSmart™
device for injection for a minimum of 24 months.